SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2022
BOSTON and LAUSANNE, Switzerland, Nov. 08, 2022 (GLOBE NEWSWIRE) — SOPHiA GENETICS SA (Nasdaq:SOPH), a cloud-native software company in the healthcare space, today reported financial results for the third quarter ended September 30, 2022.
Related news for (SOPH)
- SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain
- SOPHiA GENETICS Supports Genetic Testing in Brazil
- SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio
- SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare Conference
- SOPHiA GENETICS Reports Fourth Quarter and Year End 2022 Financial Results